Antiviral Drug Development: Overcoming Challenges To The Current Model PharmaTalkRadio podcast

Artwork

Pharmaceutical Biotech Clinical Trials Patient Engagement Immuno-oncology Drug Delivery Pharma Talk Radio Pharmacology Science Medicine RD In

Innhold levert av Pharma Talk Radio. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av Pharma Talk Radio eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.

PharmaTalkRadio »
Antiviral Drug Development: Overcoming Challenges to the Current Model

1d ago 28:00

Del

MP3•Episoder hjem

Innhold levert av Pharma Talk Radio. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av Pharma Talk Radio eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.

As viruses evolve to resist vaccines and therapeutics, new targeted approaches to deliver broad-spectrum antivirals are needed. In this podcast, Anil Diwan, President and Executive Chairman of NanoViricides Incorporated, explains some of the shortcomings of the current model of antiviral drug development and how NanoViricides developed a nanotechnology with a different approach to develop and deliver antiviral drugs. Anil also presents an overview of the scientific and clinical development of NanoViricides lead program, NV-387 as well as potential applications in different indications. For more information about NanoViricides Incorporated, visit NanoViricides.com. For more information about the annual PODD drug delivery conference, please visit Drug-Delivery.org.

… continue reading

350 episoder

#Pharmaceutical #Biotech #Clinical Trials #Patient Engagement #Immuno-oncology #Drug Delivery #Pharma Talk Radio #Pharmacology #Science #Medicine #RD In

Artwork

Antiviral Drug Development: Overcoming Challenges to the Current Model

PharmaTalkRadio

146 subscribers

published 1d ago

Del

MP3•Episoder hjem

Innhold levert av Pharma Talk Radio. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av Pharma Talk Radio eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.

As viruses evolve to resist vaccines and therapeutics, new targeted approaches to deliver broad-spectrum antivirals are needed. In this podcast, Anil Diwan, President and Executive Chairman of NanoViricides Incorporated, explains some of the shortcomings of the current model of antiviral drug development and how NanoViricides developed a nanotechnology with a different approach to develop and deliver antiviral drugs. Anil also presents an overview of the scientific and clinical development of NanoViricides lead program, NV-387 as well as potential applications in different indications. For more information about NanoViricides Incorporated, visit NanoViricides.com. For more information about the annual PODD drug delivery conference, please visit Drug-Delivery.org.

… continue reading

350 episoder

#Pharmaceutical #Biotech #Clinical Trials #Patient Engagement #Immuno-oncology #Drug Delivery #Pharma Talk Radio #Pharmacology #Science #Medicine #RD In

All episodes

×

Velkommen til Player FM!

Player FM scanner netter for høykvalitets podcaster som du kan nyte nå. Det er den beste podcastappen og fungerer på Android, iPhone og internett. Registrer deg for å synkronisere abonnement på flere enheter.

Lytt til 500+ tema